Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Mutant-specific kinase inhibitors and TAT highlights

Prof Jean-Charles Soria - Institut Gustave Roussy, Paris, France

Mutant-specific kinase inhibitors and TAT highlights ( Prof Jean-Charles Soria - Institut Gustave Roussy, Paris, France )

Drugging the cancer genome to overcome drug resistance

Prof Paul Workman - Institute of Cancer Research, UK

Drugging the cancer genome to overcome drug resistance ( Prof Paul Workman - Institute of Cancer Research, UK )

ecancermedicalscience editor's choice for February 2015

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

ecancermedicalscience editor's choice for February 2015 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )

Adjuvant treatment with sorafenib or sunitinib does not improve outcomes in...

Dr Mark Beresford - Royal United Hospitals Bath, Bath, UK

Adjuvant treatment with sorafenib or sunitinib does not improve outcomes in localised renal carcinoma ( Dr Mark Beresford - Royal United Hospitals Bath, Bath, UK )

Expert commentary on emerging research in genitourinary cancer

Dr Chris Parker - The Royal Marsden Hospital, London, UK

Expert commentary on emerging research in genitourinary cancer ( Dr Chris Parker - The Royal Marsden Hospital, London, UK )

Combination of dalantercept plus axitinib versus placebo plus axitinib in...

Dr Martin Voss - Memorial Sloan Kettering Cancer Centre, New York City, USA

Combination of dalantercept plus axitinib versus placebo plus axitinib in advanced clear cell renal cell carcinoma ( Dr Martin Voss - Memorial Sloan Kettering Cancer Centre, New York City, USA )

VEGF targeted therapy and chemo an active combination in rapidly progressive...

Dr Rana McKay - Dana-Farber Cancer Institute, Boston, USA

VEGF targeted therapy and chemo an active combination in rapidly progressive renal cell carcinoma ( Dr Rana McKay - Dana-Farber Cancer Institute, Boston, USA )

Impact of statins on survival outcomes in metastatic renal cell carcinoma

Dr Rana McKay - Dana-Farber Cancer Institute, Boston, USA

Impact of statins on survival outcomes in metastatic renal cell carcinoma ( Dr Rana McKay - Dana-Farber Cancer Institute, Boston, USA )

Combination of abiraterone and cabazitaxel in metastatic castration-resistant...

Dr Joaquin Mateo - Institute of Cancer Research, London, UK

Combination of abiraterone and cabazitaxel in metastatic castration-resistant prostate cancer ( Dr Joaquin Mateo - Institute of Cancer Research, London, UK )

Management after radical prostatectomy: early adjuvant radiotherapy or wait-and...

Dr Mohammad Parvez Shaikh - Loyola University Medical Centre, Maywood, USA

Management after radical prostatectomy: early adjuvant radiotherapy or wait-and-see? ( Dr Mohammad Parvez Shaikh - Loyola University Medical Centre, Maywood, USA )

Is there a role for androgen deprivation therapy combined with radiotherapy in...

Prof Abdenour Nabid - Sherbrooke University Hospital Centre, Sherbrooke, Canada

Is there a role for androgen deprivation therapy combined with radiotherapy in intermediate risk prostate cancer? ( Prof Abdenour Nabid - Sherbrooke University Hospital Centre, Sherbrooke, Canada )

When and whether to conduct endocrine therapy in non-metastatic prostate cancer

Dr Frederik Birkebæk Thomsen - University of Copenhagen, Copenhagen, Denmark

When and whether to conduct endocrine therapy in non-metastatic prostate cancer ( Dr Frederik Birkebæk Thomsen - University of Copenhagen, Copenhagen, Denmark )

More from ecancer